Dr. Burhan Mohamedali is a board-certified advanced heart failure and heart transplant cardiologist. He specializes in the treatment of patients with a range of cardiac conditions, including congestive heart failure, hypertrophic cardiomyopathy, pulmonary hypertension, cardiac amyloidosis, heart transplantation, and left ventricular assist devices (LVADs). Dr. Mohamedali earned his Medical Doctorate from the University of Kentucky and completed his residency in internal medicine, followed by cardiology training, at the University of Illinois at Chicago (UIC).
Driven by his passion for advanced heart failure, pulmonary hypertension, mechanical circulatory assist devices, and heart transplantation, after his cardiology training, he pursued specialized training in the field of heart failure. He completed a fellowship in advanced heart failure and transplant cardiology through UIC at Advocate Christ Medical Center in Oak Lawn, Illinois. Prior to moving to San Diego, Dr Mohamedali was the director of the Congestive Heart Failure/Heart Transplant and ECMO Program at Rush University Medical Center in Chicago.
Dr. Mohamedali has a notable academic and research background, having delivered numerous research presentations at various society meetings, including ISHLT, ACC, AHA, HFSA, AATS, and ASAIO. He has contributed to published manuscripts in diverse areas related to heart failure, left ventricular assist devices (LVADs), heart transplantation, and stem cell therapy for congestive heart failure. Notably, he authored a book chapter on heart failure in patients requiring kidney transplantation.
In addition to his academic pursuits, Dr. Mohamedali has been recognized as a distinguished speaker at both national and international conferences, including the Taiwanese Society of Cardiology, Indian College of Cardiology, and East African Society of Cardiology.
Currently, Dr. Mohamedali serves as the director of the Congestive Heart Failure Program at CVISD. He is also the Medical Director of the Congestive Heart Failure Program at Sharp Chula Vista Medical Center, where he actively participates in numerous quality improvement projects. His dedication to excellence in healthcare earned him a recent nomination for a core award for quality.
Beyond his professional responsibilities, Dr. Mohamedali is an avid enthusiast of outdoor activities, including hiking, camping, and nature exploration. He is also an amateur astronomer with a profound interest in planetary science, black holes, and neutron stars.
Left atrial appendage occlusion using a Watchman device in a transplanted heart with biatrial anastomosis.
Poulin MF, Mohamedali B, Kavinsky CJ, Krishnan K.
Catheter Cardiovasc Interv. 2019 Mar 1;93(4):758-760. doi: 10.1002/ccd.28027. Epub 2018 Dec 13.
Intensity-Dependent Benefit of Statins in Survival Among Prospective Kidney Transplant Patients.
Co MLF, Agdamag AC, Co MZ, Hertl M, Mohamedali B.
Am J Cardiol. 2019 Jan 15;123(2):254-259. doi: 10.1016/j.amjcard.2018.09.037. Epub 2018 Oct 18.
The Influence of Pre-Left Ventricular Assist Device (LVAD) Implantation Glomerular Filtration Rate on Long-Term LVAD Outcomes.
Mohamedali B, Bhat G.
Heart Lung Circ. 2017 Nov;26(11):1216-1223. doi: 10.1016/j.hlc.2017.01.002. Epub 2017 Feb 17.
PMID: 28342643 Clinical Trial.
Pre-transplant depression as a predictor of adherence and morbidities after orthotopic heart transplantation.
Delibasic M, Mohamedali B, Dobrilovic N, Raman J.
J Cardiothorac Surg. 2017 Jul 25;12(1):62. doi: 10.1186/s13019-017-0626-0.
Mean Arterial Pressure to Central Venous Pressure Ratio: A Novel Marker for Right Ventricular Failure After Left Ventricular Assist Device Placement.
Mohamedali B, Doukky R, Karavalos K, Avery E, Bhat G.
J Card Fail. 2017 Jun;23(6):446-452. doi: 10.1016/j.cardfail.2017.03.009. Epub 2017 Mar 29.
Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
Mohamedali B, Yost G, Bhat G.
Tex Heart Inst J. 2017 Apr 1;44(2):115-119. doi: 10.14503/THIJ-15-5698. eCollection 2017 Apr.
Acute Heart Failure Exacerbation with Cardiogenic Shock and Elevated Systemic Vascular Resistance Treated with a Combination of Nicardipine and Dobutamine Therapy.
Issac LE, Fugar S, Yamani N, Mohamedali B.
Case Rep Cardiol. 2017;2017:7329213. doi: 10.1155/2017/7329213. Epub 2017 Aug 6.
Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials.
Poulin MF, Deka A, Mohamedali B, Schaer GL.
Cell Transplant. 2016 Nov;25(11):1911-1923. doi: 10.3727/096368916X692087.
PMID: 27349212 Review.
Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
Mohamedali B, Pyle J, Bhat G.
Am J Clin Pathol. 2016 Feb;145(2):238-43. doi: 10.1093/ajcp/aqv026. Epub 2016 Jan 14.
Changes in Spirometry After Left Ventricular Assist Device Implantation.
Mohamedali B, Bhat G, Yost G, Tatooles A.
Artif Organs. 2015 Dec;39(12):1046-50. doi: 10.1111/aor.12507. Epub 2015 May 21.
Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
J Card Fail. 2015 Oct;21(10):800-5. doi: 10.1016/j.cardfail.2015.06.006. Epub 2015 Jun 18.
Clinical outcomes in sensitized heart transplant patients bridged with ventricular assist devices.
Kidambi S, Mohamedali B, Bhat G.
Clin Transplant. 2015 Jun;29(6):499-505. doi: 10.1111/ctr.12540. Epub 2015 Apr 30.
Survival on biventricular mechanical support with the Centrimag® as a bridge to decision: a single-center risk stratification.
Perfusion. 2015 Apr;30(3):201-8. doi: 10.1177/0267659114563947. Epub 2014 Dec 18.
Use of a single circuit to provide temporary mechanical respiratory and circulatory support in patients with LV apical thrombus and cardiogenic shock.
Mohamedali B, Tatooles A, Bhat G.
Perfusion. 2014 Nov;29(6):483-7. doi: 10.1177/0267659114538482. Epub 2014 Jun 10.
Mechanical circulatory support improves diabetic control in patients with advanced heart failure.
Eur J Heart Fail. 2014 Oct;16(10):1120-4. doi: 10.1002/ejhf.166.
Calcified amorphous tumor of the left ventricular outflow tract.
Mohamedali B, Tatooles A, Zelinger A.
Ann Thorac Surg. 2014 Mar;97(3):1053-5. doi: 10.1016/j.athoracsur.2013.06.115.
Neurogenic stress cardiomyopathy in heart donors.
Mohamedali B, Bhat G, Tatooles A, Zelinger A.
J Card Fail. 2014 Mar;20(3):207-11. doi: 10.1016/j.cardfail.2013.12.017. Epub 2013 Dec 25.
PMID: 24374112 Review.
Impact of smoking status on cardiovascular outcomes following percutaneous coronary intervention.
Mohamedali B, Shroff A.
Clin Cardiol. 2013 Jul;36(7):372-7. doi: 10.1002/clc.22134. Epub 2013 May 13.
Frequency and pattern of left ventricular dysfunction in potential heart donors: implications regarding use of dysfunctional hearts for successful transplantation.
Mohamedali B, Bhat G, Zelinger A.
J Am Coll Cardiol. 2012 Jul 17;60(3):235-6. doi: 10.1016/j.jacc.2012.04.016.